Paasa Logo
Idorsia Ltd logo
IDIASIXMarket closedOpens 9:00am CET

Idorsia Ltd

CHF 4.44Last updated
+CHF 0.06 (1.32%)Past day
Timezone

Idorsia Ltd (SIX: IDIA) is trading at CHF 4.44, about ₹512 at today's CHF/INR rate, as of 29 Sep 2026, 11:30 AM ET, up 1.32% today. Indian residents can buy Idorsia from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:CHF 4.41
Previous close:CHF 4.38
Volume:917.35K

Today's low

CHF 4.37

Today's high

CHF 4.57

52 week low

CHF 2.80

52 week high

CHF 7.56

IDIA opened at CHF 4.41, closed previously at CHF 4.38, and has traded between CHF 2.80 and CHF 7.56 over the past 52 weeks.

About

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada. The company has a clinical development pipeline for various therapeutic areas, such as CNS, cardiovascular, immunological disorders, and orphan diseases. It offers QUVIVIQ (daridorexant) for the treatment of insomnia. The company’s product pipeline includes Lucerastat, a glucosylceramide synthase inhibitor, which is in phase 3 clinical trial to treat fabry disease; Daridorexant, a dual orexin receptor antagonist, which is in phase 2 clinical trial for the treatment of pediatric insomnia; IDOR-1117-2520, a CCR6 receptor antagonist which is in phase 1 clinical program to treat psoriasis; ACT-777991, a CXCR3 antagonist, which is in preclinical trial to treat vitiligo; and ACT-1004-1239, an ACKR3 receptor antagonist which is preclinical trial for the treatment of progressive multiple sclerosis. It also develops ACT-1016-0707, a LPA 1 receptor antagonist to treat immune-mediated and fibrosis related disorders; IDOR-1141-8472, an orexin 2 receptor agonist to treat orexin-related CNS disorders; and IDOR-1126-6421 to treat organ injury. The company holds a license agreement with Neuro to develop and commercialize clazosentan; collaboration agreement with Janssen Biotech Inc. to jointly develop and commercialize aprocitentan and its derivative compounds or products; and collaboration with Viatris Inc. to develop and commercialize selatogrel and cenerimod. Idorsia Ltd was incorporated in 2017 and is headquartered in Allschwil, Switzerland.

Country
CH
CEO
Jean-Paul Clozel
Exchange listed on
SIX
Industry
Biotechnology
Base currency
CHF
Full Time Employees
456
Sector
Healthcare
IPO date
16/06/2017

Key statistics

Avg. volume

1.53M

Market cap

CHF 1.17B

P/E Ratio

-3.39

Price-to-sales ratio

5.84

Enterprise value

CHF 2.09B

Free cash flow yield

-18.26%

Debt-to-equity ratio

-1.10

Return on equity

9.85%

ROIC

-39.62%

Beta

1.64

Dividend yield

0.00%

Last dividend

CHF 0.00

Financial overview

Revenue

CHF 221.00M

Earnings per share

-CHF 0.52

Free cash flow

-CHF 167.05M

Net profit margin

-158.28%

Gross margin

80.96%

EBITDA

-CHF 45.49M

Revenue growth

96.43%

Similar securities

This is not an investment recommendation

How to buy Idorsia from India

Indian residents can buy Idorsia shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to CHF.

  3. Search for Idorsia and place an order

    Find Idorsia by name or by its ticker, IDIA, and choose an order type. Idorsia trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Idorsia position in CHF and INR. Idorsia pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Idorsia from India

Trading and taxes when buying Idorsia from India

Trading and limits

Trading hours
9:00 am – 5:30 pm CET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneIdorsia does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained

Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

FAQs

Can Indian residents buy Idorsia stock?

Yes. Idorsia (IDIA) has been listed on the SIX Swiss Exchange since 2017, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to CHF. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

How much does one Idorsia share cost in rupees?

One Idorsia share is CHF 4.44 — about ₹512 at a CHF/INR rate of 115.47 on 28 Sep 2026. Both the Idorsia price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Idorsia from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

How are gains on Idorsia shares taxed in India?

Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the CHF/INR rate on the purchase and the sale date, so the rupee move counts alongside the Idorsia price. Paasa issues a capital-gains statement for your return.

Does Idorsia pay a dividend?

No. Idorsia does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Idorsia from India?

The SIX Swiss Exchange trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when Switzerland is on standard time. Orders can only execute during that window.

Do I have to declare Idorsia shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Idorsia holding, its cost and its closing value.

How do I sell Idorsia and bring the money back to India?

You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in CHF in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.

Does the rupee rate affect what I make on Idorsia?

Yes. Idorsia is priced in CHF, so your rupee outcome combines the CHF move with the CHF/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.